Ingebjørg Seljeflot
Position: Professor, PhD FESC
Phone: +47 2211 9323
Email:

Fax:+47 2211 7970

 

Author network for Ingebjørg Seljeflot by COREMINE medical


Publications 2017

Bratseth V, Byrkjeland R, Njerve IU, Solheim S, Arnesen H, Seljeflot I (2017)
Procoagulant activity in patients with combined type 2 diabetes and coronary artery disease: No effects of long-term exercise training
Diab Vasc Dis Res, 14 (2), 144-151
PubMed 28111966

Byrkjeland R, Njerve IU, Arnesen H, Seljeflot I, Solheim S (2017)
Reduced endothelial activation after exercise is associated with improved HbA1c in patients with type 2 diabetes and coronary artery disease
Diab Vasc Dis Res, 14 (2), 94-103
PubMed 28111980

Chiva-Blanch G, Laake K, Myhre P, Bratseth V, Arnesen H, Solheim S, Badimon L, Seljeflot I (2017)
Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity
PLoS One, 12 (2), e0172558
PubMed 28207887

Cwikiel J, Seljeflot I, Berge E, Arnesen H, Wachtell K, Ulsaker H, Flaa A (2017)
Pro-coagulant activity during exercise testing in patients with coronary artery disease
Thromb J, 15, 3
PubMed 28115916

Ellingsen DG, Seljeflot I, Thomassen Y, Thomassen M, Bakke B, Ulvestad B (2017)
Biomarkers of endothelial activation and thrombosis in tunnel construction workers exposed to airborne contaminants
Int Arch Occup Environ Health, 90 (4), 309-317
PubMed 28124139

Heier M, Borja MS, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Dahl-Jørgensen K, Oda MN (2017)
Reduced HDL function in children and young adults with type 1 diabetes
Cardiovasc Diabetol, 16 (1), 85
PubMed 28683835

Heier M, Stensæth KH, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Dahl-Jørgensen K (2017)
Increased arterial stiffness in childhood onset diabetes: a cardiovascular magnetic resonance study
Eur Heart J Cardiovasc Imaging (in press)
PubMed 28950341

Hove-Skovsgaard M, Gaardbo JC, Kolte L, Winding K, Seljeflot I, Svardal A, Berge RK, Gerstoft J, Ullum H, Trøseid M, Nielsen SD (2017)
HIV-infected persons with type 2 diabetes show evidence of endothelial dysfunction and increased inflammation
BMC Infect Dis, 17 (1), 234
PubMed 28356058

Laake K, Seljeflot I, Schmidt EB, Myhre P, Tveit A, Norseth J, Arnesen H, Solheim S (2017)
Galectin-3, a marker of cardiac remodeling, is inversely related to serum levels of marine omega-3 fatty acids. A cross-sectional study
JRSM Cardiovasc Dis, 6, 2048004017729984
PubMed 28932392

Njerve IU, Akra S, Weiss TW, Solheim S, Ovstebo R, Aass HCD, Byrkjeland R, Arnesen H, Seljeflot I (2017)
A Double-Blinded Randomized Study Investigating a Possible Anti-Inflammatory Effect of Saxagliptin versus Placebo as Add-On Therapy in Patients with Both Type 2 Diabetes And Stable Coronary Artery Disease
Mediat. Inflamm., 5380638

Opstad TB, Seljeflot I, Bøhmer E, Arnesen H, Halvorsen S (2017)
MMP-9 and Its Regulators TIMP-1 and EMMPRIN in Patients with Acute ST-Elevation Myocardial Infarction: A NORDISTEMI Substudy
Cardiology, 139 (1), 17-24 (in press)
PubMed 29141241

Ritschel V, Shetelig C, Seljeflot I, Limalanathan S, Hoffmann P, Halvorsen S, Arnesen H, Eritsland J, Andersen GØ (2017)
Evaluation of circulating levels of CCN2/connective tissue growth factor in patients with ST-elevation myocardial infarction
Sci Rep, 7 (1), 11945
PubMed 28931920

Shetelig C, Limalanathan S, Eritsland J, Hoffmann P, Seljeflot I, Gran JM, Aukrust P, Ueland T, Andersen GØ (2017)
Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function
PLoS One, 12 (3), e0173034
PubMed 28253327

Warlo EMK, Pettersen AR, Arnesen H, Seljeflot I (2017)
vWF/ADAMTS13 is associated with on-aspirin residual platelet reactivity and clinical outcome in patients with stable coronary artery disease
Thromb J, 15, 28
PubMed 29200971

Wexels F, Dahl OE, Pripp AH, Seljeflot I (2017)
Thrombin Generation in Patients With Suspected Venous Thromboembolism
Clin Appl Thromb Hemost, 23 (5), 416-421
PubMed 28335612

Publications 2016

Bliksøen M, Mariero LH, Torp MK, Baysa A, Ytrehus K, Haugen F, Seljeflot I, Vaage J, Valen G, Stensløkken KO (2016)
Extracellular mtDNA activates NF-κB via toll-like receptor 9 and induces cell death in cardiomyocytes
Basic Res Cardiol, 111 (4), 42
PubMed 27164906

Byrkjeland R, Stensæth KH, Anderssen S, Njerve IU, Arnesen H, Seljeflot I, Solheim S (2016)
Effects of exercise training on carotid intima-media thickness in patients with type 2 diabetes and coronary artery disease. Influence of carotid plaques
Cardiovasc Diabetol, 15, 13
PubMed 26801098

Chiva-Blanch G, Bratseth V, Ritschel V, Andersen GØ, Halvorsen S, Eritsland J, Arnesen H, Badimon L, Seljeflot I (2016)
Monocyte-derived circulating microparticles (CD14+, CD14+/CD11b+ and CD14+/CD142+) are related to long-term prognosis for cardiovascular mortality in STEMI patients
Int J Cardiol, 227, 876-881
PubMed 27915085

Haissman JM, Haugaard AK, Knudsen A, Kristoffersen US, Seljeflot I, Pedersen KK, Lebech AM, Hasbak P, Kjær A, Ostrowski SR, Gerstoft J, Trøseid M, Nielsen SD (2016)
Marker of Endothelial Dysfunction Asymmetric Dimethylarginine Is Elevated in HIV Infection but Not Associated With Subclinical Atherosclerosis
J Acquir Immune Defic Syndr, 73 (5), 507-513
PubMed 27509250

Helseth R, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2016)
The Time Course of Markers of Neutrophil Extracellular Traps in Patients Undergoing Revascularisation for Acute Myocardial Infarction or Stable Angina Pectoris
Mediators Inflamm, 2016, 2182358
PubMed 28074081

Horjen AW, Ulimoen SR, Enger S, Norseth J, Seljeflot I, Arnesen H, Tveit A (2016)
Troponin I levels in permanent atrial fibrillation-impact of rate control and exercise testing
BMC Cardiovasc Disord, 16, 79
PubMed 27142292

Laake K, Seljeflot I, Schmidt EB, Myhre P, Tveit A, Arnesen H, Solheim S (2016)
Serum Fatty Acids, Traditional Risk Factors, and Comorbidity as Related to Myocardial Injury in an Elderly Population with Acute Myocardial Infarction
J Lipids, 2016, 4945720
PubMed 26989512

Myhre PL, Laake K, Seljeflot I, Solheim S, Arnesen H (2016)
[Clinical research on elderly]
Tidsskr Nor Laegeforen, 136 (3), 208
PubMed 26860377

Neerland BE, Hall RJ, Seljeflot I, Frihagen F, MacLullich AM, Raeder J, Wyller TB, Watne LO (2016)
Associations Between Delirium and Preoperative Cerebrospinal Fluid C-Reactive Protein, Interleukin-6, and Interleukin-6 Receptor in Individuals with Acute Hip Fracture
J Am Geriatr Soc, 64 (7), 1456-63
PubMed 27341529

Njerve IU, Byrkjeland R, Arnesen H, Åkra S, Solheim S, Seljeflot I (2016)
Effects of long-term exercise training on adipose tissue expression of fractalkine and MCP-1 in patients with type 2 diabetes and stable coronary artery disease: a substudy of a randomized controlled trial
Diabetes Metab Syndr Obes, 9, 55-62
PubMed 27042130

Opstad TB, Arnesen H, Pettersen AÅ, Seljeflot I (2016)
Combined Elevated Levels of the Proinflammatory Cytokines IL-18 and IL-12 Are Associated with Clinical Events in Patients with Coronary Artery Disease: An Observational Study
Metab Syndr Relat Disord, 14 (5), 242-8
PubMed 27058587

Opstad TB, Brusletto BS, Arnesen H, Pettersen AÅ, Seljeflot I (2016)
Cigarette smoking represses expression of cytokine IL-12 and its regulator miR-21-An observational study in patients with coronary artery disease
Immunobiology, 222 (2), 169-175
PubMed 27765464

Ritschel VN, Seljeflot I, Arnesen H, Halvorsen S, Eritsland J, Fagerland MW, Andersen GØ (2016)
Circulating Levels of IL-6 Receptor and gp130 and Long-Term Clinical Outcomes in ST-Elevation Myocardial Infarction
J Am Heart Assoc, 5 (6)
PubMed 27412895

Wexels F, Seljeflot I, Pripp AH, Dahl OE (2016)
D-Dimer and prothrombin fragment 1 + 2 in urine and plasma in patients with clinically suspected venous thromboembolism
Blood Coagul Fibrinolysis, 27 (4), 396-400
PubMed 26595215

Publications 2015

Andric T, Weiss TW, Huber K, Arnesen H, Seljeflot I (2015)
Effects of diet and/or n-3 fatty acid supplementation on components of the interleukin-6 trans-signalling system in elderly men
Scand J Clin Lab Invest, 75 (8), 646-51
PubMed 26179891

Berg IJ, van der Heijde D, Dagfinrud H, Seljeflot I, Olsen IC, Kvien TK, Semb AG, Provan SA (2015)
Disease activity in ankylosing spondylitis and associations to markers of vascular pathology and traditional cardiovascular disease risk factors: a cross-sectional study
J Rheumatol, 42 (4), 645-53
PubMed 25641897

Byrkjeland R, Njerve IU, Anderssen S, Arnesen H, Seljeflot I, Solheim S (2015)
Effects of exercise training on HbA1c and VO2peak in patients with type 2 diabetes and coronary artery disease: A randomised clinical trial
Diab Vasc Dis Res, 12 (5), 325-33
PubMed 26092822

Ellingsen DG, Ulvestad B, Bakke B, Seljeflot I, Barregard L, Thomassen Y (2015)
Serum pneumoproteins in tunnel construction workers
Int Arch Occup Environ Health, 88 (7), 943-51
PubMed 25632885

Hansen CH, Ritschel V, Halvorsen S, Andersen GØ, Bjørnerheim R, Eritsland J, Arnesen H, Seljeflot I (2015)
Markers of thrombin generation are associated with myocardial necrosis and left ventricular impairment in patients with ST-elevation myocardial infarction
Thromb J, 13, 31
PubMed 26396552

Heier M, Margeirsdottir HD, Gaarder M, Stensæth KH, Brunborg C, Torjesen PA, Seljeflot I, Hanssen KF, Dahl-Jørgensen K (2015)
Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study
Cardiovasc Diabetol, 14, 126
PubMed 26408307

Heier M, Margeirsdottir HD, Torjesen PA, Seljeflot I, Stensæth KH, Gaarder M, Brunborg C, Hanssen KF, Dahl-Jørgensen K (2015)
The advanced glycation end product methylglyoxal-derived hydroimidazolone-1 and early signs of atherosclerosis in childhood diabetes
Diab Vasc Dis Res, 12 (2), 139-45
PubMed 25616705

Helseth R, Opstad T, Solheim S, Lunde K, Arnesen H, Seljeflot I (2015)
The Effect of Intracoronary Stem Cell Injection on Markers of Leukocyte Activation in Acute Myocardial Infarction
Cardiol Res, 6 (1), 209-215
PubMed 28197227

Horjen AW, Ulimoen SR, Seljeflot I, Smith P, Arnesen H, Norseth J, Tveit A (2015)
High-Sensitivity Troponin I and Rhythm Outcome after Electrical Cardioversion for Persistent Atrial Fibrillation
Cardiology, 133 (4), 233-8
PubMed 26697854

Lindholm EE, Aune E, Seljeflot I, Otterstad JE, Kirkebøen KA (2015)
Biomarkers of inflammation in major vascular surgery: a prospective randomised trial
Acta Anaesthesiol Scand, 59 (6), 773-87
PubMed 25626738

Laake K, Seljeflot I, Fagerland MW, Njerve IU, Arnesen H, Solheim S (2015)
Effects on serum fractalkine by diet and omega-3 fatty acid intervention: relation to clinical outcome
Mediators Inflamm, 2015, 373070
PubMed 25733777

Pettersen AA, Arnesen H, Seljeflot I (2015)
A brief review on high on-aspirin residual platelet reactivity
Vascul Pharmacol, 67-69, 6-9
PubMed 25869498

Skrede K, Wyller TB, Watne LO, Seljeflot I, Juliebø V (2015)
Is there a role for monocyte chemoattractant protein-1 in delirium? Novel observations in elderly hip fracture patients
BMC Res Notes, 8, 186
PubMed 25943983

Trøseid M, Nestvold TK, Nielsen EW, Thoresen H, Seljeflot I, Lappegård KT (2015)
Soluble CD14 is associated with markers of vascular dysfunction in bariatric surgery patients
Metab Syndr Relat Disord, 13 (3), 119-24
PubMed 25562385

Publications 2014

Byrkjeland R, Edvardsen E, Njerve IU, Arnesen H, Seljeflot I, Solheim S (2014)
Insulin levels and HOMA index are associated with exercise capacity in patients with type 2 diabetes and coronary artery disease
Diabetol Metab Syndr, 6 (1), 36
PubMed 24612649

Furenes EB, Opstad TB, Solheim S, Lunde K, Arnesen H, Seljeflot I (2014)
The influence of autologous bone marrow stem cell transplantation on matrix metalloproteinases in patients treated for acute ST-elevation myocardial infarction
Mediators Inflamm, 2014, 385901
PubMed 25294955

Heier M, Margeirsdottir HD, Brunborg C, Hanssen KF, Dahl-Jørgensen K, Seljeflot I (2014)
Inflammation in childhood type 1 diabetes; influence of glycemic control
Atherosclerosis, 238 (1), 33-7
PubMed 25437887

Helseth R, Seljeflot I, Opstad T, Solheim S, Freynhofer M, Arnesen H, Huber K, Weiss T (2014)
Genes expressed in coronary thrombi are associated with ischemic time in patients with acute myocardial infarction
Thromb Res, 135 (2), 329-33
PubMed 25496999

Helseth R, Solheim S, Opstad T, Hoffmann P, Arnesen H, Seljeflot I (2014)
The time profile of Pentraxin 3 in patients with acute ST-elevation myocardial infarction and stable angina pectoris undergoing percutaneous coronary intervention
Mediators Inflamm, 2014, 608414
PubMed 24737925

Husebye T, Eritsland J, Arnesen H, Bjørnerheim R, Mangschau A, Seljeflot I, Andersen GØ (2014)
Association of interleukin 8 and myocardial recovery in patients with ST-elevation myocardial infarction complicated by acute heart failure
PLoS One, 9 (11), e112359
PubMed 25390695

Laake K, Myhre P, Nordby LM, Seljeflot I, Abdelnoor M, Smith P, Tveit A, Arnesen H, Solheim S (2014)
Effects of ω3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled study
BMC Geriatr, 14, 74
PubMed 24928284

Njerve IU, Solheim S, Lunde K, Hoffmann P, Arnesen H, Seljeflot I (2014)
Fractalkine levels are elevated early after PCI-treated ST-elevation myocardial infarction; no influence of autologous bone marrow derived stem cell injection
Cytokine, 69 (1), 131-5
PubMed 24930044

Opstad TB, Arnesen H, Pettersen AÅ, Seljeflot I (2014)
The MMP-9 -1562 C/T polymorphism in the presence of metabolic syndrome increases the risk of clinical events in patients with coronary artery disease
PLoS One, 9 (9), e106816
PubMed 25191702

Pedersen KK, Manner IW, Seljeflot I, Kvale D, Os I, Gerstoft J, Nielsen SD, Trøseid M (2014)
Monocyte activation, but not microbial translocation, is independently associated with markers of endovascular dysfunction in HIV-infected patients receiving cART
J Acquir Immune Defic Syndr, 67 (4), 370-4
PubMed 25226210

Sveen KA, Dahl-Jørgensen K, Stensaeth KH, Angel K, Seljeflot I, Sell DR, Monnier VM, Hanssen KF (2014)
Glucosepane and oxidative markers in skin collagen correlate with intima media thickness and arterial stiffness in long-term type 1 diabetes
J Diabetes Complications, 29 (3), 407-12
PubMed 25600701

Svendsen M, Tonstad S, Heggen E, Pedersen TR, Seljeflot I, Bøhn SK, Bastani NE, Blomhoff R, Holme IM, Klemsdal TO (2014)
The effect of kiwifruit consumption on blood pressure in subjects with moderately elevated blood pressure: a randomized, controlled study
Blood Press, 24 (1), 48-54
PubMed 25483553

Wexels F, Dahl OE, Pripp AH, Seljeflot I, Borris LC, Haslund A, Gudmundsen TE, Lauritzen T, Lassen MR (2014)
Prothrombin fragment 1+2 in urine as a marker on coagulation activity in patients with suspected pulmonary embolism
Thromb Res, 134 (1), 68-71
PubMed 24824294

Wonnerth A, Katsaros KM, Krychtiuk KA, Speidl WS, Kaun C, Thaler K, Huber K, Wojta J, Maurer G, Seljeflot I, Arnesen H, Weiss TW (2014)
Glycoprotein 130 polymorphism predicts soluble glycoprotein 130 levels
Metabolism, 63 (5), 647-53
PubMed 24629561

Publications 2013

Arnesen H, Seljeflot I (2013)
The challenge of judging data on the effects of N-3 fatty acids in CHD
Scand Cardiovasc J, 47 (2), 67-8
PubMed 23327650

Berge T, Ulimoen SR, Enger S, Arnesen H, Seljeflot I, Tveit A (2013)
Impact of atrial fibrillation on inflammatory and fibrinolytic variables in the elderly
Scand J Clin Lab Invest, 73 (4), 326-33
PubMed 23586783

Husebye T, Eritsland J, Müller C, Sandvik L, Arnesen H, Seljeflot I, Mangschau A, Bjørnerheim R, Andersen GØ (2013)
Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study
Eur J Heart Fail, 15 (5), 565-72
PubMed 23288914

Lindholm EE, Aune E, Norén CB, Seljeflot I, Hayes T, Otterstad JE, Kirkeboen KA (2013)
The anesthesia in abdominal aortic surgery (ABSENT) study: a prospective, randomized, controlled trial comparing troponin T release with fentanyl-sevoflurane and propofol-remifentanil anesthesia in major vascular surgery
Anesthesiology, 119 (4), 802-12
PubMed 23838709

Opstad TB, Pettersen AÅ, Arnesen H, Seljeflot I (2013)
The co-existence of the IL-18+183 A/G and MMP-9 -1562 C/T polymorphisms is associated with clinical events in coronary artery disease patients
PLoS One, 8 (9), e74498
PubMed 24040261

Ritschel VN, Seljeflot I, Arnesen H, Halvorsen S, Weiss T, Eritsland J, Andersen GØ (2013)
IL-6 signalling in patients with acute ST-elevation myocardial infarction
Results Immunol, 4, 8-13
PubMed 24707455

Rønning B, Wyller TB, Jordhøy MS, Nesbakken A, Bakka A, Seljeflot I, Kristjansson SR (2013)
Frailty indicators and functional status in older patients after colorectal cancer surgery
J Geriatr Oncol, 5 (1), 26-32
PubMed 24484715

Solheim S, Seljeflot I, Lunde K, Bratseth V, Aakhus S, Forfang K, Arnesen H (2013)
Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy
Thromb J, 11 (1), 1
PubMed 23311309

Tveit A, Seljeflot I, Smith P, Arnesen H, Svendsen JH (2013)
Angiotensin II blockade, YKL-40 and maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation
Immunobiology, 218 (10), 1256-60
PubMed 23731775

Weiss TW, Arnesen H, Seljeflot I (2013)
Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness
Metabolism, 62 (7), 1008-13
PubMed 23428306

Wexels F, Haslund A, Dahl OE, Pripp AH, Gudmundsen TE, Laszlo F, Seljeflot I, Borris LC, Lassen MR (2013)
Thrombin split products (prothrombin fragment 1 + 2) in urine in patients with suspected deep vein thrombosis admitted for radiological verification
Thromb Res, 131 (6), 560-3
PubMed 23680105

Publications 2012

Angel K, Provan SA, Mowinckel P, Seljeflot I, Kvien TK, Atar D (2012)
The L-arginine/asymmetric dimethylarginine ratio is improved by anti-tumor necrosis factor-α therapy in inflammatory arthropathies. Associations with aortic stiffness
Atherosclerosis, 225 (1), 160-5
PubMed 23014354

Bliksøen M, Mariero LH, Ohm IK, Haugen F, Yndestad A, Solheim S, Seljeflot I, Ranheim T, Andersen GØ, Aukrust P, Valen G, Vinge LE (2012)
Increased circulating mitochondrial DNA after myocardial infarction
Int J Cardiol, 158 (1), 132-4
PubMed 22578950

Bratseth V, Pettersen AÅ, Opstad TB, Arnesen H, Seljeflot I (2012)
Markers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatment
Thromb J, 10 (1), 12
PubMed 22883224

Fraser DA, Diep LM, Hovden IA, Nilsen KB, Sveen KA, Seljeflot I, Hanssen KF (2012)
The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial
Diabetes Care, 35 (5), 1095-7
PubMed 22446172

Fraser DA, Diep LM, Hovden IA, Nilsen KB, Sveen KA, Seljeflot I, Hanssen KF (2012)
Response to Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095-1097
Diabetes Care, 35 (11), E80

Halvorsen S, Seljeflot I, Weiss T, Bøhmer E, Arnesen H (2012)
Inflammatory and thrombotic markers in patients with ST-elevation myocardial infarction treated with thrombolysis and early PCI: a NORDISTEMI substudy
Thromb Res, 130 (3), 495-500
PubMed 22607887

Hassellund SS, Flaa A, Kjeldsen SE, Seljeflot I, Karlsen A, Erlund I, Rostrup M (2012)
Effects of anthocyanins on cardiovascular risk factors and inflammation in pre-hypertensive men: a double-blind randomized placebo-controlled crossover study
J Hum Hypertens, 27 (2), 100-6
PubMed 22336903

Karlsen A, Svendsen M, Seljeflot I, Laake P, Duttaroy AK, Drevon CA, Arnesen H, Tonstad S, Blomhoff R (2012)
Kiwifruit decreases blood pressure and whole-blood platelet aggregation in male smokers
J Hum Hypertens, 27 (2), 126-30
PubMed 22258209

Lindholm E, Seljeflot I, Aune E, Kirkebøen KA (2012)
Proinflammatory cytokines and complement activation in salvaged blood from abdominal aortic aneurism surgery and total hip replacement surgery
Transfusion, 52 (8), 1761-9
PubMed 22304534

Njerve IU, Pettersen AÅ, Opstad TB, Arnesen H, Seljeflot I (2012)
Fractalkine and its receptor (CX3CR1) in patients with stable coronary artery disease and diabetes mellitus
Metab Syndr Relat Disord, 10 (6), 400-6
PubMed 22897138

Pettersen AÅ, Arnesen H, Opstad TB, Bratseth V, Seljeflot I (2012)
Markers of endothelial and platelet activation are associated with high on-aspirin platelet reactivity in patients with stable coronary artery disease
Thromb Res, 130 (3), 424-8
PubMed 22795340

Pettersen AÅ, Seljeflot I, Abdelnoor M, Arnesen H (2012)
High On-Aspirin Platelet Reactivity and Clinical Outcome in Patients With Stable Coronary Artery Disease: Results From ASCET (Aspirin Nonresponsiveness and Clopidogrel Endpoint Trial)
J Am Heart Assoc, 1 (3), e000703
PubMed 23130135

Seljeflot I (2012)
Plasma asymmetric dimethylarginine in patients with acute decompensation of chronic heart failure
Heart, 98 (11), 831-2
PubMed 22581731

Seljeflot I, R Ulimoen S, Enger S, Bratseth V, Arnesen H, Tveit A (2012)
Asymmetric Dimethylarginine Levels are Highly Associated With Atrial Fibrillation in an Elderly Population
Cardiol Res, 3 (3), 109-115
PubMed 28352406

Publications 2011

Andersen GØ, Knudsen EC, Aukrust P, Yndestad A, Oie E, Müller C, Seljeflot I, Ueland T (2011)
Elevated serum osteoprotegerin levels measured early after acute ST-elevation myocardial infarction predict final infarct size
Heart, 97 (6), 460-5
PubMed 21270073

Andersen GØ, Ueland T, Knudsen EC, Scholz H, Yndestad A, Sahraoui A, Smith C, Lekva T, Otterdal K, Halvorsen B, Seljeflot I, Aukrust P (2011)
Activin A levels are associated with abnormal glucose regulation in patients with myocardial infarction: potential counteracting effects of activin A on inflammation
Diabetes, 60 (5), 1544-51
PubMed 21464440

Byrkjeland R, Nilsson BB, Westheim AS, Arnesen H, Seljeflot I (2011)
Inflammatory markers as related to disease severity in patients with chronic heart failure: limited effects of exercise training
Scand J Clin Lab Invest, 71 (7), 598-605
PubMed 21831004

Grøgaard HK, Solheim S, Landsverk KS, Seljeflot I, Hoffmann P, Arnesen H, Ilebekk A (2011)
Circulating CD34⁺ progenitor cells and growth factors in patients treated with PCI for acute myocardial infarction or stable angina pectoris
Scand J Clin Lab Invest, 71 (4), 322-9
PubMed 21463159

Karlsen A, Svendsen M, Seljeflot I, Sommernes MA, Sexton J, Brevik A, Erlund I, Serafini M, Bastani N, Remberg SF, Borge GI, Carlsen MH, Bøhn SK, Myhrstad MC, Dragsted LO, Duttaroy AK, Haffner K, Laake P, Drevon CA, Arnesen H, Collins A, Tonstad S, Blomhoff R (2011)
Compliance, tolerability and safety of two antioxidant-rich diets: a randomised controlled trial in male smokers
Br J Nutr, 106 (4), 557-71
PubMed 21806852

Kirkhus B, Lamglait A, Eilertsen KE, Falch E, Haider T, Vik H, Hoem N, Hagve TA, Basu S, Olsen E, Seljeflot I, Nyberg L, Elind E, Ulven SM (2011)
Effects of similar intakes of marine n-3 fatty acids from enriched food products and fish oil on cardiovascular risk markers in healthy human subjects
Br J Nutr, 107 (9), 1339-49
PubMed 21917191

Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GO (2011)
Impact of newly diagnosed abnormal glucose regulation on long-term prognosis in low risk patients with ST-elevation myocardial infarction: A follow-up study
BMC Endocr Disord, 11, 14
PubMed 21801387

Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GØ (2011)
Elevated levels of PAI-1 activity and t-PA antigen are associated with newly diagnosed abnormal glucose regulation in patients with ST-elevation myocardial infarction
J Thromb Haemost, 9 (8), 1468-74
PubMed 21624046

Mistry N, Abdelnoor M, Seljeflot I, Hoffmann P, Bøhmer E, Bjørnerheim R, Kjeldsen SE, Halvorsen S (2011)
Amino-terminal pro-B-type natriuretic peptide (NT-proBNP) levels 3 months after myocardial infarction are more strongly associated with magnetic resonance-determined ejection fraction than NTproBNP levels in the acute phase
J Card Fail, 17 (6), 479-86
PubMed 21624736

Opstad TB, Pettersen AÅ, Arnesen H, Seljeflot I (2011)
Circulating levels of IL-18 are significantly influenced by the IL-18 +183 A/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an observational study
Cardiovasc Diabetol, 10, 110
PubMed 22141572

Opstad TB, Pettersen AA, Weiss TW, Akra S, Øvstebø R, Arnesen H, Seljeflot I (2011)
Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease
Clin Chim Acta, 413 (1-2), 113-20
PubMed 21963461

Pettersen AA, Arnesen H, Opstad TB, Seljeflot I (2011)
The influence of CYP 2C19*2 polymorphism on platelet function testing during single antiplatelet treatment with clopidogrel
Thromb J, 9, 4
PubMed 21426546

Solheim S, Seljeflot I, Lunde K, Bratseth V, Aakhus S, Forfang K, Arnesen H (2011)
The influence of intracoronary injection of bone marrow cells on prothrombotic markers in patients with acute myocardial infarction
Thromb Res, 130 (5), 765-8
PubMed 22192151

Weiss TW, Arnesen H, Trøseid M, Kaun C, Hjerkinn EM, Huber K, Wojta J, Seljeflot I (2011)
Adipose tissue expression of interleukin-18 mRNA is elevated in subjects with metabolic syndrome and independently associated with fasting glucose
Wien Klin Wochenschr, 123 (21-22), 650-4
PubMed 21842238

Weiss TW, Seljeflot I, Hjerkinn EM, Arnesen H (2011)
Adipose tissue pro-inflammatory gene expression is associated with cardiovascular disease
Int J Clin Pract, 65 (9), 939-44
PubMed 21849008

Publications 2010

Arnesen H, Seljeflot I (2010)
Studies on very long chain marine n-3 fatty acids in patients with atherosclerotic heart disease with special focus on mechanisms, dosage and formulas of supplementation
Cell Mol Biol (Noisy-le-grand), 56 (1), 18-27
PubMed 20196966

Bøhmer E, Seljeflot I, Arnesen H, Hoffmann P, Abdelnoor M, Halvorsen S (2010)
The association between metabolic syndrome and infarct size in patients with acute myocardial infarction
Scand J Clin Lab Invest, 70 (4), 287-93
PubMed 20429699

Bøhn SK, Myhrstad MC, Thoresen M, Holden M, Karlsen A, Tunheim SH, Erlund I, Svendsen M, Seljeflot I, Moskaug JO, Duttaroy AK, Laake P, Arnesen H, Tonstad S, Collins A, Drevon CA, Blomhoff R (2010)
Blood cell gene expression associated with cellular stress defense is modulated by antioxidant-rich food in a randomised controlled clinical trial of male smokers
BMC Med, 8, 54
PubMed 20846424

Grøgaard HK, Seljeflot I, Lunde K, Solheim S, Aakhus S, Forfang K, Arnesen H, Ilebekk A (2010)
Cell treatment after acute myocardial infarction prevents early decline in circulating IGF-1
Scand Cardiovasc J, 44 (5), 267-72
PubMed 21080844

Knudsen EC, Seljeflot I, Michael A, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GØ (2010)
Increased levels of CRP and MCP-1 are associated with previously unknown abnormal glucose regulation in patients with acute STEMI: a cohort study
Cardiovasc Diabetol, 9, 47
PubMed 20809989

Kringen MK, Haug KB, Grimholt RM, Stormo C, Narum S, Opdal MS, Fosen JT, Piehler AP, Johansen PW, Seljeflot I, Berg JP, Brørs O (2010)
Genetic variation of VKORC1 and CYP4F2 genes related to warfarin maintenance dose in patients with myocardial infarction
J Biomed Biotechnol, 2011, 739751
PubMed 21127708

Kringen MK, Narum S, Lygren I, Seljeflot I, Sandset PM, Trøseid AM, Johansen PW, Brørs O, Holthe MR (2010)
Reduced platelet function and role of drugs in acute gastrointestinal bleeding
Basic Clin Pharmacol Toxicol, 108 (3), 194-201
PubMed 21118353

Nilsson BB, Westheim A, Risberg MA, Arnesen H, Seljeflot I (2010)
No effect of group-based aerobic interval training on N-terminal pro- B-type natriuretic peptide levels in patients with chronic heart failure
Scand Cardiovasc J, 44 (4), 223-9
PubMed 20636229

Opstad TB, Pettersen AA, Bratseth V, Arnesen H, Seljeflot I (2010)
The influence of tissue factor and tissue factor pathway inhibitor polymorphisms on thrombin generation in stable coronary artery disease
Pathophysiol Haemost Thromb, 37 (2-4), 98-103
PubMed 21555871

Opstad TB, Pettersen AA, Weiss T, Arnesen H, Seljeflot I (2010)
Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes
Thromb J, 8, 7
PubMed 20444258

Rønning B, Wyller TB, Seljeflot I, Jordhøy MS, Skovlund E, Nesbakken A, Kristjansson SR (2010)
Frailty measures, inflammatory biomarkers and post-operative complications in older surgical patients
Age Ageing, 39 (6), 758-61
PubMed 20843962

Seljeflot I, Nilsson BB, Westheim AS, Bratseth V, Arnesen H (2010)
The L-arginine-asymmetric dimethylarginine ratio is strongly related to the severity of chronic heart failure. No effects of exercise training
J Card Fail, 17 (2), 135-42
PubMed 21300303

Solheim S, Seljeflot I, Lunde K, Bjørnerheim R, Aakhus S, Forfang K, Arnesen H (2010)
Frequency of left ventricular thrombus in patients with anterior wall acute myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy
Am J Cardiol, 106 (9), 1197-200
PubMed 21029812

Trøseid M, Seljeflot I, Arnesen H (2010)
The role of interleukin-18 in the metabolic syndrome
Cardiovasc Diabetol, 9, 11
PubMed 20331890

Tveit A, Arnesen H, Smith P, Bratseth V, Seljeflot I (2010)
L-arginine, asymmetric dimethylarginine and rhythm outcome after electrical cardioversion for atrial fibrillation
Cardiology, 117 (3), 176-80
PubMed 21063118

Weiss TW, Furenes EB, Trøseid M, Solheim S, Hjerkinn EM, Seljeflot I, Arnesen H (2010)
Prediction of cardiovascular events by matrix metalloproteinase (MMP)-9 in elderly men
Thromb Haemost, 103 (3), 679-81
PubMed 20076844

Publications 2009

Bangstad HJ, Seljeflot I, Berg TJ, Hanssen KF (2009)
Renal tubulointerstitial expansion is associated with endothelial dysfunction and inflammation in type 1 diabetes
Scand J Clin Lab Invest, 69 (1), 138-44
PubMed 18846477

Bøhmer E, Hoffmann P, Abdelnoor M, Seljeflot I, Halvorsen S (2009)
Troponin T concentration 3 days after acute ST-elevation myocardial infarction predicts infarct size and cardiac function at 3 months
Cardiology, 113 (3), 207-12
PubMed 19218804

Furenes EB, Arnesen H, Solheim S, Grøgaard HK, Hoffmann P, Seljeflot I (2009)
The profile of circulating metalloproteinases after PCI in patients with acute myocardial infarction or stable angina
Thromb Res, 124 (5), 560-4
PubMed 19410278

Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Arnesen H, Andersen GO (2009)
Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients
Cardiovasc Diabetol, 8, 6
PubMed 19183453

Taraldsrud E, Grøgaard HK, Solheim S, Lunde K, Fløisand Y, Arnesen H, Seljeflot I, Egeland T (2009)
Age and stress related phenotypical changes in bone marrow CD34+ cells
Scand J Clin Lab Invest, 69 (1), 79-84
PubMed 18836945

Trøseid M, Arnesen H, Hjerkinn EM, Seljeflot I (2009)
Serum levels of interleukin-18 are reduced by diet and n-3 fatty acid intervention in elderly high-risk men
Metabolism, 58 (11), 1543-9
PubMed 19595382

Trøseid M, Lappegård KT, Mollnes TE, Arnesen H, Seljeflot I (2009)
The effect of exercise on serum levels of interleukin-18 and components of the metabolic syndrome
Metab Syndr Relat Disord, 7 (6), 579-84
PubMed 19900154

Trøseid M, Seljeflot I, Weiss TW, Klemsdal TO, Hjerkinn EM, Arnesen H (2009)
Arterial stiffness is independently associated with interleukin-18 and components of the metabolic syndrome
Atherosclerosis, 209 (2), 337-9
PubMed 19836750

Tveit A, Bollmann A, Seljeflot I, Husser D, Stridh M, Sörnmo L, Arnesen H, Olsson SB, Smith P (2009)
Relation between atrial fibrillatory rate and markers of inflammation and haemostasis in persistent human atrial fibrillation
Thromb Haemost, 101 (3), 601-3
PubMed 19277431

Wennersberg MH, Smedman A, Turpeinen AM, Retterstøl K, Tengblad S, Lipre E, Aro A, Mutanen P, Seljeflot I, Basu S, Pedersen JI, Mutanen M, Vessby B (2009)
Dairy products and metabolic effects in overweight men and women: results from a 6-mo intervention study
Am J Clin Nutr, 90 (4), 960-8
PubMed 19710195

Publications 2008

Brodin E, Seljeflot I, Arnesen H, Hurlen M, Appelbom H, Hansen JB (2008)
Endogenous thrombin potential (ETP) in plasma from patients with AMI during antithrombotic treatment
Thromb Res, 123 (4), 573-9
PubMed 18474393

Ellingsen I, Seljeflot I, Arnesen H, Tonstad S (2008)
Vitamin C consumption is associated with less progression in carotid intima media thickness in elderly men: A 3-year intervention study
Nutr Metab Cardiovasc Dis, 19 (1), 8-14
PubMed 18472409

Furenes EB, Seljeflot I, Solheim S, Hjerkinn EM, Arnesen H (2008)
Long-term influence of diet and/or omega-3 fatty acids on matrix metalloproteinase-9 and pregnancy-associated plasma protein-A in men at high risk of coronary heart disease
Scand J Clin Lab Invest, 68 (3), 177-84
PubMed 17934973

Grundvold I, Tveit A, Smith P, Seljeflot I, Abdelnoor M, Arnesen H (2008)
The predictive value of transthoracic echocardiographic variables for sinus rhythm maintenance after electrical cardioversion of atrial fibrillation. Results from the CAPRAF study, a prospective, randomized, placebo-controlled study
Cardiology, 111 (1), 30-5
PubMed 18239389

Haug KBF, Sharikabad MN, Kringen MK, Narum S, Sjaatil ST, Johansen PW, Kierulf P, Seljeflot I, Arnesen H, Brørs O (2008)
Warfarin dose and INR related to genotypes of CYP2C9 and VKORC1 in patients with myocardial infarction
Thromb J, 6, 7
PubMed 18559094

Solheim S, Grøgaard HK, Hoffmann P, Arnesen H, Seljeflot I (2008)
Inflammatory responses after percutaneous coronary intervention in patients with acute myocardial infarction or stable angina pectoris
Scand J Clin Lab Invest, 68 (7), 555-62
PubMed 19378426

Solheim S, Seljeflot I, Lunde K, Aukrust P, Yndestad A, Grøgaard HK, Aakhus S, Forfang K, Arnesen H (2008)
Inflammatory responses after intracoronary injection of autologous mononuclear bone marrow cells in patients with acute myocardial infarction
Am Heart J, 155 (1), 55.e1-9
PubMed 18082489

Trøseid M, Seljeflot I, Hjerkinn EM, Arnesen H (2008)
Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia
Diabetes Care, 32 (3), 486-92
PubMed 19092166

Tveit A, Grundvold I, Olufsen M, Seljeflot I, Abdelnoor M, Arnesen H, Smith P (2008)
Angiotensin receptor blockers in the prevention of atrial fibrillation recurrence: Need for a definitive trial
Int. J. Cardiol., 127 (2), 278-279

Tveit A, Seljeflot I, Grundvold I, Abdelnoor M, Arnesen H, Smith P (2008)
Candesartan, NT-proBNP and recurrence of atrial fibrillation after electrical cardioversion
Int J Cardiol, 131 (2), 234-9
PubMed 18201783

Publications 2007

Aksnes TA, Seljeflot I, Torjesen PA, Höieggen A, Moan A, Kjeldsen SE (2007)
Improved insulin sensitivity by the angiotensin II-receptor blocker losartan is not explained by adipokines, inflammatory markers, or whole blood viscosity
Metabolism, 56 (11), 1470-7
PubMed 17950096

Eid HM, Reims H, Arnesen H, Kjeldsen SE, Lyberg T, Seljeflot I (2007)
Decreased levels of asymmetric dimethylarginine during acute hyperinsulinemia
Metabolism, 56 (4), 464-9
PubMed 17379002

Ellingsen I, Hjerkinn EM, Seljeflot I, Arnesen H, Tonstad S (2007)
Consumption of fruit and berries is inversely associated with carotid atherosclerosis in elderly men
Br J Nutr, 99 (3), 674-81
PubMed 17894919

Hjelstuen A, Anderssen SA, Holme I, Seljeflot I, Klemsdal TO (2007)
Effect of lifestyle and/or statin treatment on soluble markers of atherosclerosis in hypertensives
Scand Cardiovasc J, 41 (5), 313-20
PubMed 17852781

Jonsson G, Abdelnoor M, Seljeflot I, Arnesen H, Hostmark AT, Kjeldsen SE, Os I, Westheim AS (2007)
The antioxidative effects of long-term treatment are more pronounced for carvedilol than for atenolol in post-myocardial infarction patients
J Cardiovasc Pharmacol, 49 (1), 27-32
PubMed 17261960

Khoury J, Henriksen T, Seljeflot I, Mørkrid L, Frøslie KF, Tonstad S (2007)
Effects of an antiatherogenic diet during pregnancy on markers of maternal and fetal endothelial activation and inflammation: the CARRDIP study
BJOG, 114 (3), 279-88
PubMed 17217362

Nylaende M, Kroese AJ, Morken B, Stranden E, Sandbaek G, Lindahl AK, Arnesen H, Seljeflot I (2007)
Beneficial effects of 1-year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study
Vasc Med, 12 (4), 275-83
PubMed 18048463

Nylaande M, Kroese AJ, Morken B, Stranderi E, Sandbaek G, Lindahl AK, Arnesen H, Seljeflot I (2007)
Beneficial effects of 1-year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study
Vasc. Med., 12 (4), 275-283

Tonstad S, Thorsrud H, Torjesen PA, Seljeflot I (2007)
Do novel risk factors differ between men and women aged 18 to 39 years with a high risk of coronary heart disease?
Metabolism, 56 (2), 260-6
PubMed 17224342

Tveit A, Seljeflot I, Grundvold I, Abdelnoor M, Smith P, Arnesen H (2007)
Effect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation
Am J Cardiol, 99 (11), 1544-8
PubMed 17531578

Tveit A, Seljeflot I, Grundvold I, Abdelnoor M, Smith P, Arnesen H (2007)
Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation
Thromb Res, 121 (4), 447-53
PubMed 17698170

Publications 2006

Amundsen AL, Khoury J, Sandset PM, Seljeflot I, Ose L, Tonstad S, Henriksen T, Retterstøl K, Iversen PO (2006)
Altered hemostatic balance and endothelial activation in pregnant women with familial hypercholesterolemia
Thromb Res, 120 (1), 21-7
PubMed 16914186

Bethune C, Seierstad SL, Seljeflot I, Johansen O, Arnesen H, Meltzer HM, Rosenlund G, Frøyland L, Lundebye AK (2006)
Dietary intake of differently fed salmon: a preliminary study on contaminants
Eur J Clin Invest, 36 (3), 193-201
PubMed 16506965

Eid HM, Arnesen H, Hjerkinn EM, Lyberg T, Ellingsen I, Seljeflot I (2006)
Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine
Nutr Metab (Lond), 3, 4
PubMed 16396682

Eid HM, Lyberg T, Arnesen H, Seljeflot I (2006)
Insulin and adiponectin inhibit the TNFalpha-induced ADMA accumulation in human endothelial cells: the role of DDAH
Atherosclerosis, 194 (2), e1-8
PubMed 17141242

Ellingsen I, Hjerkinn EM, Arnesen H, Seljeflot I, Hjermann I, Tonstad S (2006)
Follow-up of diet and cardiovascular risk factors 20 years after cessation of intervention in the Oslo Diet and Antismoking Study
Eur J Clin Nutr, 60 (3), 378-85
PubMed 16306931

Hjerkinn EM, Abdelnoor M, Breivik L, Bergengen L, Ellingsen I, Seljeflot I, Aase O, Ole Klemsdal T, Hjermann I, Arnesen H (2006)
Effect of diet or very long chain omega-3 fatty acids on progression of atherosclerosis, evaluated by carotid plaques, intima-media thickness and by pulse wave propagation in elderly men with hypercholesterolaemia
Eur J Cardiovasc Prev Rehabil, 13 (3), 325-33
PubMed 16926660

Nylaende M, Abdelnoor M, Stranden E, Morken B, Sandbaek G, Risum Ø, Jørgensen JJ, Lindahl AK, Arnesen H, Seljeflot I, Kroese AJ (2006)
The Oslo balloon angioplasty versus conservative treatment study (OBACT)--the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication
Eur J Vasc Endovasc Surg, 33 (1), 3-12
PubMed 17055756

Nylaende M, Kroese A, Stranden E, Morken B, Sandbaek G, Lindahl AK, Arnesen H, Seljeflot I (2006)
Markers of vascular inflammation are associated with the extent of atherosclerosis assessed as angiographic score and treadmill walking distances in patients with peripheral arterial occlusive disease
Vasc Med, 11 (1), 21-8
PubMed 16669409

Nylaende M, Kroese A, Stranden E, Morken B, Sandbaek G, Lindahl AK, Arnesen H, Seljeflot I (2006)
Prothrombotic activity is associated with the anatomical as well as the functional severity of peripheral arterial occlusive disease
Thromb Haemost, 95 (4), 702-7
PubMed 16601842

Schumacher A, Peersen K, Sommervoll L, Seljeflot I, Arnesen H, Otterstad JE (2006)
Physical performance is associated with markers of vascular inflammation in patients with coronary heart disease
Eur J Cardiovasc Prev Rehabil, 13 (3), 356-62
PubMed 16926664

Seljeflot I, Larsen JR, Dahl-Jørgensen K, Hanssen KF, Arnesen H (2006)
Fibrinolytic activity is highly influenced by long-term glycemic control in Type 1 diabetic patients
J Thromb Haemost, 4 (3), 686-8
PubMed 16460457

Solheim S, Pettersen AA, Arnesen H, Seljeflot I (2006)
No difference in the effects of clopidogrel and aspirin on inflammatory markers in patients with coronary heart disease
Thromb Haemost, 96 (5), 660-4
PubMed 17080224

Trøseid M, Hjerkinn EM, Seljeflot I, Klemsdal TO, Bergengen L, Breivik L, Arnesen H (2006)
Comparison of biochemical, functional and structural aspects of arterial wall properties in elderly men
Scand J Clin Lab Invest, 66 (2), 137-45
PubMed 16537247

Tveit A, Grundvold I, Olufsen M, Seljeflot I, Abdelnoor M, Arnesen H, Smith P (2006)
Candesartan in the prevention of relapsing atrial fibrillation
Int J Cardiol, 120 (1), 85-91
PubMed 17113170

Aas AM, Seljeflot I, Torjesen PA, Diep LM, Thorsby PM, Birkeland KI (2006)
Blood glucose lowering by means of lifestyle intervention has different effects on adipokines as compared with insulin treatment in subjects with type 2 diabetes
Diabetologia, 49 (5), 872-80
PubMed 16555056

Publications 2005

Hjerkinn EM, Seljeflot I, Ellingsen I, Berstad P, Hjermann I, Sandvik L, Arnesen H (2005)
Influence of long-term intervention with dietary counseling, long-chain n-3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia
Am J Clin Nutr, 81 (3), 583-9
PubMed 15755826

Hjerkinn EM, Seljeflot I, Sandvik L, Hjermann I, Arnesen H (2005)
Markers of endothelial cell activation in elderly men at high risk for coronary heart disease
Scand J Clin Lab Invest, 65 (3), 201-9
PubMed 16095049

Hurlen M, Eikvar L, Seljeflot I, Arnesen H (2005)
Occult bleeding in three different antithrombotic regimes after myocardial infarction. A WARIS-II subgroup analysis
Thromb Res, 118 (4), 433-8
PubMed 16139331

Lindman AS, Pedersen JI, Arnesen H, Hjerkinn EM, Seljeflot I (2005)
Association between the factor VII haplotype containing the -402A allele and myocardial infarction in a population of elderly men at high risk for coronary heart disease
Thromb Haemost, 94 (1), 226-7
PubMed 16116695

Lindman AS, Pedersen JI, Hjerkinn EM, Veierød MB, Kavlie A, Arnesen H, Seljeflot I (2005)
The influence of the -401G/T and -402G/A polymorphisms of the coagulation FVII promoter on plasma levels of FVII
Thromb Res, 116 (4), 313-20
PubMed 16038716

Pedersen JI, Muller H, Seljeflot I, Kirkhus B (2005)
Palm oil versus hydrogenated soybean oil: effects on serum lipids and plasma haemostatic variables
Asia Pac J Clin Nutr, 14 (4), 348-57
PubMed 16326641

Schumacher A, Seljeflot I, Lerkerød AB, Sommervoll L, Otterstad JE, Arnesen H (2005)
Chlamydia LPS and MOMP seropositivity are associated with different cytokine profiles in patients with coronary heart disease
Eur J Clin Invest, 35 (7), 431-7
PubMed 16008544

Seierstad SL, Seljeflot I, Johansen O, Hansen R, Haugen M, Rosenlund G, Frøyland L, Arnesen H (2005)
Dietary intake of differently fed salmon; the influence on markers of human atherosclerosis
Eur J Clin Invest, 35 (1), 52-9
PubMed 15638820

Tonstad S, Sundfør T, Seljeflot I (2005)
Effect of lifestyle changes on atherogenic lipids and endothelial cell adhesion molecules in young adults with familial premature coronary heart disease
Am J Cardiol, 95 (10), 1187-91
PubMed 15877991

Trøseid M, Lappegård KT, Mollnes TE, Arnesen H, Seljeflot I (2005)
Changes in serum levels of E-selectin correlate to improved glycaemic control and reduced obesity in subjects with the metabolic syndrome
Scand J Clin Lab Invest, 65 (4), 283-90
PubMed 16076683

Publications 2004

Biong AS, Müller H, Seljeflot I, Veierød MB, Pedersen JI (2004)
A comparison of the effects of cheese and butter on serum lipids, haemostatic variables and homocysteine
Br J Nutr, 92 (5), 791-7
PubMed 15533268

Eid HM, Arnesen H, Hjerkinn EM, Lyberg T, Seljeflot I (2004)
Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine
Metabolism, 53 (12), 1574-9
PubMed 15562402

Johansen O, Brekke M, Seljeflot I, Semb AG, Arnesen H (2004)
Blood platelet count and reactivity are associated with restenosis 6 months after coronary angioplasty
Scand Cardiovasc J, 38 (4), 211-5
PubMed 15553931

Lindman AS, Pedersen JI, Arnesen H, Hjerkinn EM, Veierød MB, Prydz H, Seljeflot I (2004)
Coagulation factor VII, R353Q polymorphism, and serum choline-containing phospholipids in males at high risk for coronary heart disease
Thromb Res, 113 (1), 57-65
PubMed 15081566

Lindman AS, Pedersen JI, Hjerkinn EM, Arnesen H, Veierød MB, Ellingsen I, Seljeflot I (2004)
The effects of long-term diet and omega-3 fatty acid supplementation on coagulation factor VII and serum phospholipids with special emphasis on the R353Q polymorphism of the FVII gene
Thromb Haemost, 91 (6), 1097-104
PubMed 15175795

Mansoor MA, Seljeflot I, Arnesen H, Knudsen A, Bates CJ, Mishra G, Larsen TW (2004)
Endothelial cell adhesion molecules in healthy adults during acute hyperhomocysteinemia and mild hypertriglyceridemia
Clin Biochem, 37 (5), 408-14
PubMed 15087258

Pettersen AA, Seljeflot I, Abdelnoor M, Arnesen H (2004)
Unstable angina, stroke, myocardial infarction and death in aspirin non-responders. A prospective, randomized trial. The ASCET (ASpirin non-responsiveness and Clopidogrel Endpoint Trial) design
Scand Cardiovasc J, 38 (6), 353-6
PubMed 15804802

Seljeflot I, Hurlen M, Arnesen H (2004)
Increased levels of soluble tissue factor during long-term treatment with warfarin in patients after an acute myocardial infarction
J Thromb Haemost, 2 (5), 726-30
PubMed 15099277

Seljeflot I, Hurlen M, Solheim S, Arnesen H (2004)
Serum levels of interleukin-10 are inversely related to future events in patients with acute myocardial infarction
J Thromb Haemost, 2 (2), 350-2
PubMed 14996010

Seljeflot I, Lyberg T, Arnesen H (2004)
Soluble tissue factor in plasma from patients with acute myocardial infarction is not microvesicle-associated
PROCEEDINGS OF THE 18TH INTERNATIONAL CONGRESS ON THROMBOSIS, 11-15

Veitenhansl M, Stegner K, Hierl FX, Dieterle C, Feldmeier H, Gutt B, Landgraf R, Garrow AP, Vileikyte L, Findlow A, Waterman C, Boulton AJ, Shankhdhar K, Shankhdhar L, Shankhdhar U, Petrova NL, Foster AV, Edmonds ME, Ferraresi R, Caravaggi C, De Giglio R, Cavaiani P, Pogliaghi I, Sommariva E, Katz IA et al. (2004)
40th EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004
Diabetologia, 47 (Suppl 1), A1-A464
PubMed 27770180

Publications 2003

Arnesen H, Dahl OE, Aspelin T, Seljeflot I, Kierulf P, Lyberg T (2003)
Sustained prothrombotic profile after hip replacement surgery: the influence of prolonged prophylaxis with dalteparin
J Thromb Haemost, 1 (5), 971-5
PubMed 12871363

Berstad P, Seljeflot I, Veierød MB, Hjerkinn EM, Arnesen H, Pedersen JI (2003)
Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1
Clin Sci (Lond), 105 (1), 13-20
PubMed 12589702

Eid HM, Eritsland J, Larsen J, Arnesen H, Seljeflot I (2003)
Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin
Atherosclerosis, 166 (2), PII S0021-9150(02)00206-X-284

Eid HM, Eritsland J, Larsen J, Arnesen H, Seljeflot I (2003)
Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin
Atherosclerosis, 166 (2), 279-84
PubMed 12535740

Lindman AS, Müller H, Seljeflot I, Prydz H, Veierød M, Pedersen JI (2003)
Effects of dietary fat quantity and composition on fasting and postprandial levels of coagulation factor VII and serum choline-containing phospholipids
Br J Nutr, 90 (2), 329-36
PubMed 12908893

Müller H, Lindman AS, Blomfeldt A, Seljeflot I, Pedersen JI (2003)
A diet rich in coconut oil reduces diurnal postprandial variations in circulating tissue plasminogen activator antigen and fasting lipoprotein (a) compared with a diet rich in unsaturated fat in women
J Nutr, 133 (11), 3422-7
PubMed 14608053

Seljeflot I, Hurlen M, Hole T, Arnesen H (2003)
Soluble tissue factor as predictor of future events in patients with acute myocardial infarction
Thromb Res, 111 (6), 369-72
PubMed 14698655

Solheim S, Arnesen H, Eikvar L, Hurlen M, Seljeflot I (2003)
Influence of aspirin on inflammatory markers in patients after acute myocardial infarction
Am J Cardiol, 92 (7), 843-5
PubMed 14516890

Publications 2002

Andersen K, Hurlen M, Arnesen H, Seljeflot I (2002)
Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease
Thromb Res, 108 (1), 37-42
PubMed 12586130

Apeland T, Mansoor MA, Pentieva K, McNulty H, Seljeflot I, Strandjord RE (2002)
The effect of B-vitamins on hyperhomocysteinemia in patients on antiepileptic drugs
Epilepsy Res., 51 (3), PII S0920-1211(02)00153-5-247

Apeland T, Mansoor MA, Pentieva K, McNulty H, Seljeflot I, Strandjord RE (2002)
The effect of B-vitamins on hyperhomocysteinemia in patients on antiepileptic drugs
Epilepsy Res, 51 (3), 237-47
PubMed 12399074

Apeland T, Mansoor MA, Seljeflot I, Brønstad I, Gøransson L, Strandjord RE (2002)
Homocysteine, malondialdehyde and endothelial markers in dialysis patients during low-dose folinic acid therapy
J Intern Med, 252 (5), 456-64
PubMed 12528764

Eid HM, Lyberg T, Larsen J, Arnesen H, Seljeflot I (2002)
Reactive oxygen species generation by leukocytes in populations at risk for atherosclerotic disease
Scand J Clin Lab Invest, 62 (6), 431-9
PubMed 12469898

Olesen M, Kwong E, Meztli A, Kontny F, Seljeflot I, Arnesen H, Lyngdorf L, Falk E (2002)
No effect of cyclooxygenase inhibition on plaque size in atherosclerosis-prone mice
Scand Cardiovasc J, 36 (6), 362-7
PubMed 12626204

Os I, Djurovic S, Seljeflot I, Berg K (2002)
Transforming growth factor (TGF)-beta1 inversely related to vascular cell adhesion molecule-1 in postmenopausal women with coronary artery disease. A possible mechanism for the putative cardioprotective role of TGF-beta1?
J Intern Med, 251 (3), 223-7
PubMed 11886481

Os I, Os A, Sandset PM, Bølling S, Seljeflot I, Djurovic S, Westheim A (2002)
Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine
Cardiology, 98 (1-2), 6-12
PubMed 12373040

Schumacher A, Seljeflot I, Lerkerod AB, Sommervoll L, Otterstad JE, Arnesen H (2002)
Positive Chlamydia pneumoniae serology is associated with elevated levels of tumor necrosis factor alpha in patients with coronary heart disease
Atherosclerosis, 164 (1), PII S0021-9150(02)00043-6-160

Schumacher A, Seljeflot I, Lerkerød AB, Sommervoll L, Otterstad JE, Arnesen H (2002)
Does infection with Chlamydia pneumoniae and/or Helicobacter pylori increase the expression of endothelial cell adhesion molecules in humans?
Clin Microbiol Infect, 8 (10), 654-61
PubMed 12390284

Schumacher A, Seljeflot I, Lerkerød AB, Sommervoll L, Otterstad JE, Arnesen H (2002)
Positive Chlamydia pneumoniae serology is associated with elevated levels of tumor necrosis factor alpha in patients with coronary heart disease
Atherosclerosis, 164 (1), 153-60
PubMed 12119204

Schumacher A, Seljeflot I, Sommervoll L, Christensen B, Otterstad JE, Arnesen H (2002)
Increased levels of endothelial haemostatic markers in patients with coronary heart disease
Thromb Res, 105 (1), 25-31
PubMed 11864703

Schumacher A, Seljeflot I, Sommervoll L, Christensen B, Otterstad JE, Arnesen H (2002)
Increased levels of markers of vascular inflammation in patients with coronary heart disease
Scand J Clin Lab Invest, 62 (1), 59-68
PubMed 12002414

Schumacher A, Seljeflot I, Sommervoll L, Christensen B, Otterstad JE, Arnesen H (2002)
Increased levels of endothelial haemostatic markers in patients with coronary heart disease
Thromb. Res., 105 (1), PII S0049-3848(01)00399-1-31

Seljeflot I, Tonstad S, Hjermann I, Arnesen H (2002)
Reduced expression of endothelial cell markers after 1 year treatment with simvastatin and atorvastatin in patients with coronary heart disease
Atherosclerosis, 162 (1), PII S0021-9150(01)00696-7-185

Seljeflot I, Tonstad S, Hjermann I, Arnesen H (2002)
Improved fibrinolysis after 1-year treatment with HMG CoA reductase inhibitors in patients with coronary heart disease
Thromb. Res., 105 (4), PII S0049-3848(02)00034-8-290

Seljeflot I, Tonstad S, Hjermann I, Arnesen H (2002)
Improved fibrinolysis after 1-year treatment with HMG CoA reductase inhibitors in patients with coronary heart disease
Thromb Res, 105 (4), 285-90
PubMed 12031821

Seljeflot I, Tonstad S, Hjermann I, Arnesen H (2002)
Reduced expression of endothelial cell markers after 1 year treatment with simvastatin and atorvastatin in patients with coronary heart disease
Atherosclerosis, 162 (1), 179-85
PubMed 11947912

Yli-Jama P, Seljeflot I, Meyer HE, Hjerkinn EM, Arnesen H, Pedersen JI (2002)
Serum non-esterified very long-chain PUFA are associated with markers of endothelial dysfunction
Atherosclerosis, 164 (2), PII S0021-9150(02)00067-9-281

Yli-Jama P, Seljeflot I, Meyer HE, Hjerkinn EM, Arnesen H, Pedersen JI (2002)
Serum non-esterified very long-chain PUFA are associated with markers of endothelial dysfunction
Atherosclerosis, 164 (2), 275-81
PubMed 12204798

Publications 2001

Guzic-Salobir B, Keber I, Seljeflot I, Arnesen H, Vrabic L (2001)
Combined hormone replacement therapy improves endothelial function in healthy postmenopausal women
J Intern Med, 250 (6), 508-15
PubMed 11902819

Hurlen M, Hole T, Seljeflot I, Arnesen H (2001)
Aspirin does not influence the effect of angiotensin-converting enzyme inhibition on left ventricular ejection fraction 3 months after acute myocardial infarction
Eur J Heart Fail, 3 (2), 203-7
PubMed 11246058

Johansen O, Abdelnoor M, Brekke M, Seljeflot I, Høstmark AT, Arnesen H (2001)
Predictors of restenosis after coronary angioplasty. A study on demographic and metabolic variables
Scand Cardiovasc J, 35 (2), 86-91
PubMed 11405502

Müller H, Seljeflot I, Solvoll K, Pedersen JI (2001)
Partially hydrogenated soybean oil reduces postprandial t-PA activity compared with palm oil
Atherosclerosis, 155 (2), 467-76
PubMed 11254919

Schumacher A, Lerkerød AB, Seljeflot I, Sommervoll L, Holme I, Otterstad JE, Arnesen H (2001)
Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals
J Clin Microbiol, 39 (5), 1859-64
PubMed 11326004

Solheim S, Seljeflot I, Arnesen H, Eritsland J, Eikvar L (2001)
Reduced levels of TNF alpha in hypercholesterolemic individuals after treatment with pravastatin for 8 weeks
Atherosclerosis, 157 (2), 411-5
PubMed 11472741

Publications 2000

Hoibraaten E, Os I, Seljeflot I, Andersen TO, Hofstad A, Sandset PM (2000)
The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: results from the estrogen in women with atherosclerosis study
Thromb Res, 98 (1), 19-27
PubMed 10706930

Hurlen M, Seljeflot I, Arnesen H (2000)
Increased platelet aggregability during exercise in patients with previous myocardial infarction. Lack of inhibition by aspirin
Thromb Res, 99 (5), 487-94
PubMed 10973679

Seljeflot I, Arnesen H, Hofstad AE, Os I (2000)
Reduced expression of endothelial cell markers after long-term transdermal hormone replacement therapy in women with coronary artery disease
Thromb Haemost, 83 (6), 944-8
PubMed 10896253

Publications 1999

Brude IR, Finstad HS, Seljeflot I, Drevon CA, Solvoll K, Sandstad B, Hjermann I, Arnesen H, Nenseter MS (1999)
Plasma homocysteine concentration related to diet, endothelial function and mononuclear cell gene expression among male hyperlipidaemic smokers
Eur J Clin Invest, 29 (2), 100-8
PubMed 10092996

Johansen O, Brekke M, Seljeflot I, Abdelnoor M, Arnesen H (1999)
N-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study. Coronary Angioplasty Restenosis Trial
J Am Coll Cardiol, 33 (6), 1619-26
PubMed 10334433

Johansen O, Seljeflot I, Høstmark AT, Arnesen H (1999)
The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease
Arterioscler Thromb Vasc Biol, 19 (7), 1681-6
PubMed 10397685

Seljeflot I, Arnesen H, Andersen P, Aspelin T, Kierulf P (1999)
Effects of doxazosin and atenolol on circulating endothelin-1 and von Willebrand factor in hypertensive middle-aged men
J Cardiovasc Pharmacol, 34 (4), 584-8
PubMed 10511135

Seljeflot I, Johansen O, Arnesen H, Eggesbø JB, Westvik AB, Kierulf P (1999)
Procoagulant activity and cytokine expression in whole blood cultures from patients with atherosclerosis supplemented with omega-3 fatty acids
Thromb Haemost, 81 (4), 566-70
PubMed 10235440

Publications 1998

Andersen P, Seljeflot I, Herzog A, Arnesen H, Hjermann I, Holme I (1998)
Effects of doxazosin and atenolol on atherothrombogenic risk profile in hypertensive middle-aged men
J Cardiovasc Pharmacol, 31 (5), 677-83
PubMed 9593066

Hurlen M, Seljeflot I, Arnesen H (1998)
The effect of different antithrombotic regimens on platelet aggregation after myocardial infarction
Scand Cardiovasc J, 32 (4), 233-7
PubMed 9802142

Johansen O, Brekke M, Strømme JH, Valen V, Seljeflot I, Skjaeggestad O, Arnesen H (1998)
Myocardial damage during percutaneous transluminal coronary angioplasty as evidenced by troponin T measurements
Eur Heart J, 19 (1), 112-7
PubMed 9503183

Müller H, Jordal O, Seljeflot I, Kierulf P, Kirkhus B, Ledsaak O, Pedersen JI (1998)
Effect on plasma lipids and lipoproteins of replacing partially hydrogenated fish oil with vegetable fat in margarine
Br J Nutr, 80 (3), 243-51
PubMed 9875064

Seljeflot I, Arnesen H, Brude IR, Nenseter MS, Drevon CA, Hjermann I (1998)
Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers
Eur J Clin Invest, 28 (8), 629-35
PubMed 9767357

Seljeflot I, Moan A, Aspelin T, Tønnessen T, Kjeldsen SE, Arnesen H (1998)
Circulating levels of endothelin-1 during acute hyperinsulinemia in patients with essential hypertension treated with type 1 angiotensin receptor antagonist or placebo
Metabolism, 47 (3), 292-6
PubMed 9500565

Strømme JH, Johansen O, Brekke M, Seljeflot I, Arnesen H (1998)
Markers of myocardial injury in blood following PTCA: a comparison of CKMB, cardiospecific troponin T and troponin I
Scand J Clin Lab Invest, 58 (8), 693-9
PubMed 10088207

Publications 1997

Brude IR, Drevon CA, Hjermann I, Seljeflot I, Lund-Katz S, Saarem K, Sandstad B, Solvoll K, Halvorsen B, Arnesen H, Nenseter MS (1997)
Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants
Arterioscler Thromb Vasc Biol, 17 (11), 2576-88
PubMed 9409230

Publications 1996

Almendingen K, Seljeflot I, Sandstad B, Pedersen JI (1996)
Effects of partially hydrogenated fish oil, partially hydrogenated soybean oil, and butter on hemostatic variables in men
Arterioscler Thromb Vasc Biol, 16 (3), 375-80
PubMed 8630662

Moan A, Høieggen A, Seljeflot I, Risanger T, Arnesen H, Kjeldsen SE (1996)
The effect of angiotensin II receptor antagonism with losartan on glucose metabolism and insulin sensitivity
J Hypertens, 14 (9), 1093-7
PubMed 8986909

Seljeflot I, Moan A, Kjeldsen S, Sandvik E, Arnesen H (1996)
Effect of angiotensin II receptor blockade on fibrinolysis during acute hyperinsulinemia in patients with essential hypertension
Hypertension, 27 (6), 1299-304
PubMed 8641739

Publications 1995

Andersen P, Seljeflot I, Abdelnoor M, Arnesen H, Dale PO, Løvik A, Birkeland K (1995)
Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome
Metabolism, 44 (5), 611-6
PubMed 7752909

Dahl OE, Aspelin T, Arnesen H, Seljeflot I, Kierulf P, Ruyter R, Lyberg T (1995)
Increased activation of coagulation and formation of late deep venous thrombosis following discontinuation of thromboprophylaxis after hip replacement surgery
Thromb Res, 80 (4), 299-306
PubMed 8585042

Eritsland J, Arnesen H, Berg K, Seljeflot I, Abdelnoor M (1995)
Serum Lp(a) lipoprotein levels in patients with coronary artery disease and the influence of long-term n-3 fatty acid supplementation
Scand J Clin Lab Invest, 55 (4), 295-300
PubMed 7569731

Eritsland J, Arnesen H, Seljeflot I, Høstmark AT (1995)
Long-term metabolic effects of n-3 polyunsaturated fatty acids in patients with coronary artery disease
Am J Clin Nutr, 61 (4), 831-6
PubMed 7702027

Eritsland J, Arnesen H, Seljeflot I, Kierulf P (1995)
Long-term effects of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease
Blood Coagul Fibrinolysis, 6 (1), 17-22
PubMed 7795149

Eritsland J, Gjønnes G, Sandset PM, Seljeflot I, Arnesen H (1995)
Activated protein C resistance and graft occlusion after coronary artery bypass surgery
Thromb Res, 79 (2), 223-6
PubMed 7676409

Eritsland J, Seljeflot I, Arnesen H, Westvik AB, Kierulf P (1995)
Effect of long-term, moderate-dose supplementation with omega-3 fatty acids on monocyte procoagulant activity and release of interleukin-6 in patients with coronary artery disease
Thromb Res, 77 (4), 337-46
PubMed 7740525

SELJEFLOT I, ARNESEN H, STOEN R, LYBERG T (1995)
EFFECTS OF INSULIN AND SOME VASOCONSTRICTORS ON THE SYNTHESIS AND RELEASE OF T-PA AND PAI-1 FROM CULTURED HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS
Fibrinolysis, 9 (4), 253-257

Publications 1994

Eritsland J, Arnesen H, Seljeflot I, Abdelnoor M, Grønseth K, Berg K, Malinow MR (1994)
Influence of serum lipoprotein(a) and homocyst(e)ine levels on graft patency after coronary artery bypass grafting
Am J Cardiol, 74 (11), 1099-102
PubMed 7977066

ERITSLAND J, SELJEFLOT I, ABDELNOOR M, ARNESEN H (1994)
LONG-TERM INFLUENCE OF OMEGA-3-FATTY-ACIDS ON FIBRINOLYSIS, FIBRINOGEN, AND SERUM-LIPIDS
Fibrinolysis, 8 (2), 120-125

Eritsland J, Seljeflot I, Abdelnoor M, Arnesen H, Torjesen PA (1994)
Long-term effects of n-3 fatty acids on serum lipids and glycaemic control
Scand J Clin Lab Invest, 54 (4), 273-80
PubMed 7939369

Seljeflot I, Eritsland J, Andersen P, Arnesen H (1994)
Global fibrinolytic capacity assessed by the serum D-dimer test. Correlation between basal and stimulated values
Thromb Res, 75 (2), 157-62
PubMed 7974389

Seljeflot I, Eritsland J, Torjesen P, Arnesen H (1994)
Insulin and PAI-1 levels during oral glucose tolerance test in patients with coronary heart disease
Scand J Clin Lab Invest, 54 (3), 241-6
PubMed 8036449

Seljeflot I, Haaland AH, Arnesen H (1994)
Stability of plasma PAI-I at room temperature
Thromb Res, 73 (1), 75-8
PubMed 8178316

Publications 1993

Dahl OE, Pedersen T, Kierulf P, Westvik AB, Lund P, Arnesen H, Seljeflot I, Abdelnoor M, Lyberg T (1993)
Sequential intrapulmonary and systemic activation of coagulation and fibrinolysis during and after total hip replacement surgery
Thromb Res, 70 (6), 451-8
PubMed 8362370

SELJEFLOT I, ARNESEN H, ERITSLAND J, SMITH P (1993)
D-DIMER TEST AFTER STANDARDIZED COAGULATION - A NEW ASSAY FOR GLOBAL EVALUATION OF THE UNSTIMULATED FIBRINOLYTIC SYSTEM
Fibrinolysis, 7 (5), 303-307

Publications 1992

Eritsland J, Seljeflot I, Arnesen H, Smith P, Westvik AB (1992)
Effects of long-term treatment with warfarin on fibrinogen, FPA, TAT, and D-dimer in patients with coronary artery disease
Thromb Res, 66 (1), 55-60
PubMed 1412183

Publications 1990

Andersen P, Smith P, Seljeflot I, Brataker S, Arnesen H (1990)
Effects of gemfibrozil on lipids and haemostasis after myocardial infarction
Thromb Haemost, 63 (2), 174-7
PubMed 2194314

Smith P, Seljeflot I, Opstad T (1990)
Withdrawal of chronic beta-adrenoceptorblockade: effects on haemodynamics, blood lipids and haemostatic variables
Eur J Clin Pharmacol, 39 (1), 81-2
PubMed 1980463

Publications 1989

Eritsland J, Arnesen H, Smith P, Seljeflot I, Dahl K (1989)
Effects of highly concentrated omega-3 polyunsaturated fatty acids and acetylsalicylic acid, alone and combined, on bleeding time and serum lipid profile
J Oslo City Hosp, 39 (8-9), 97-101
PubMed 2809856

Publications 1987

Arnesen H, Engebretsen LF, Ugland OM, Seljeflot I, Kierulf P (1987)
Increased fibrinolytic activity after surgery induced by low dose heparin
Thromb Res, 45 (5), 553-9
PubMed 3109060